ERNA vs KLAC · P/E 0.0, rev $582.0K vs P/E 55, rev $12.16B
Eterna Therapeutics Inc (ERNA) versus KLA Corporation (KLAC) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
KLA Corporation (KLAC) is a semiconductor equipment & materials company listed on US.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported KLAC revenue for 2025-06-30 was $12.16B. Net income was $4.06B. KLAC currently screens at market cap $252.01B and trailing P/E 54.7.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. KLAC currently screens at market cap $252.01B and trailing P/E 54.7.
Not investment advice. Open the ERNA and KLAC stock pages for the full models.
Not investment advice.